主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RYTM
#1011
Rhythm Pharmaceuticals, Inc. Common Stock
92.730
0
-4.28%
版块:
基础:
利润货币:
日范围
年范围
日变化
-4.28%
每月变动
-11.82%
6个月变化
-15.94%
年变化
-15.94%
前一天收盘价
96.880
0
Open
92.830
0
Bid
Ask
Low
92.730
0
High
92.830
0
交易量
161
市场
股票
医疗保健
RYTM
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
50.18 M
50.33 M
56.75 M
60.14 M
63.22 M
68.29 M
—
Valuation ratios
Enterprise value
1.39 B
443.04 M
1.5 B
2.65 B
3.45 B
7.25 B
21.27 B
Price to earnings ratio
—
-7.13
-8.25
-14.1
-12.9
-34.42
-107.08
Price to sales ratio
—
156.95
63.15
33.62
26.24
—
—
Price to cash flow ratio
—
3.39
8.61
19.12
29.98
60.13
184.39
Price to book ratio
—
1.74
5.65
15.33
157.14
50.02
179.92
Enterprise value to EBITDA ratio
—
-2.61
-8.19
-13.05
-11.72
—
—
Profitability ratios
Return on assets %
0.72
0.21
0.47
0.56
0.66
0.41
0.46
Return on equity %
0.8
0.24
0.69
1.09
11.99
1.41
7.23
Return on invested capital %
11.27 K
4 279.65
3 215.48
2 584.26
2 491.51
1 914.72
1 057.99
Gross margin %
—
81.01
90.98
87.99
89.73
89.73
358.31
Operating margin %
—
5 391.85
757.92
238.1
204.04
101.19
421.96
EBITDA margin %
—
-5 376.82
-773.17
-262.61
-226.26
-127
—
Net margin %
—
2 207.1
766.22
238.52
200.27
103.57
433.6
Liquidity ratios
Quick ratio
—
7.1
8.83
5.43
3.08
4.16
14.47
Current ratio
10.1
7.1
8.9
5.58
3.24
4.41
15.24
Inventory turnover
—
5.4
1.41
1.61
0.98
0.88
0.95
Asset turnover
0
0.01
0.07
0.22
0.36
0.43
0.44
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.28
0.21
0.98
Long term debt to total equity ratio
—
—
—
—
4.98
0.73
16.02
Per share metrics
Operating cash flow per share
—
2.94
3.33
2.36
1.87
1.78
1.8
EBIT per share
—
-3.44
-3.52
-3.54
-4.84
-3.72
-2.98
EBITDA per share
—
-3.42
-3.51
-3.53
-4.83
-3.71
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
5.94
6.39
4.78
5.26
5.98
21.82
Net current asset value per share
—
6.22
6.8
5.35
6.13
7.19
26.17
Tangible book value per share
—
5.63
4.92
2.82
0.26
2.06
4.52
Working capital per share
—
5.34
6.03
4.39
4.24
5.55
19.16
Book value per share
—
5.73
5.07
2.94
0.36
2.14
4.87
新闻
Guggenheim上调Rhythm Pharmaceuticals目标价,基于公司业绩指引
Guggenheim raises Rhythm Pharmaceuticals stock price target on guidance
Citizens上调Rhythm Pharmaceuticals目标价,看好HO适应症获批前景
Citizens raises Rhythm Pharmaceuticals stock price target on HO approval outlook
Stifel重申Rhythm Pharmaceuticals股票买入评级,目标价131美元
Stifel reiterates Buy on Rhythm Pharmaceuticals stock, $131 target
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
Rhythm Pharma 2025年第四季度业绩:营收超预期,HO适应症获批在即
Rhythm Pharma Q4 2025 slides: revenue beats as HO launch nears
Rhythm PharmaQ4每股收益及营收超出预期
Rhythm Pharma earnings beat by $0.09, revenue topped estimates
Rhythm Pharma财报公布在即,关键肥胖症批准决定临近